Abstract Details
|
Catherine Zhao
PRESENTER |
Ms. Zhao has nothing to disclose. |
| Shreya Dhar | Ms. Dhar has received personal compensation for serving as an employee of Northwestern University . |
| Ian G. Sherrington | Mr. Sherrington has nothing to disclose. |
| Ryan A. Tesh | Mr. Tesh has nothing to disclose. |
| Brian Coughlin | Mr. Coughlin has nothing to disclose. |
| Alice D. Lam, MD, PhD | Dr. Lam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurona Therapeutics. Dr. Lam has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals. The institution of Dr. Lam has received research support from Neurona Therapeutics. The institution of Dr. Lam has received research support from NIH. The institution of Dr. Lam has received research support from Alzheimer's Association. |
| Sydney Cash, MD (Massachusetts General Hospital) | Dr. Cash has received stock or an ownership interest from Beacon Biosignals. |
| M. B. Westover, MD, PhD (MGH) | Dr. Westover has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Beacon Biosignals. Dr. Westover has stock in Beacon Biosignals. The institution of Dr. Westover has received research support from NIH. Dr. Westover has received publishing royalties from a publication relating to health care. Dr. Westover has a non-compensated relationship as a cofounder with Beacon Biosignals that is relevant to AAN interests or activities. |
| Eyal Y. Kimchi, MD, PhD (Northwestern University) | The institution of Dr. Kimchi has received research support from NIH. The institution of an immediate family member of Dr. Kimchi has received research support from NIH. |